Stopmigren tablets are prescribed to quickly alleviate the condition with migraine attacks, with or without an aura.
Composition and form of release
The active component of the drug is sumatriptan.
Release form Stopmigraine – tablets.
One Stopmigraine tablet contains 50 mg of sumatriptan.
Antimigraine pharmaceutical drug. Its use helps to stop or weaken a migraine attack, as well as to eliminate photophobia (photophobia) and nausea associated with a migraine attack. When using this medication, there is a selective narrowing of the vessels of the carotid artery system dilated during a migraine attack. At the same time, taking this drug does not affect cerebral blood flow.
The medicine Stopmigraine is used to relieve migraine attacks with or without aura.
Stopmigraine is prohibited in case of hypersensitivity to it, stroke (also suffered), ischemic heart disease, severe hepatic / renal failure, occlusive peripheral vascular disease, uncontrolled arterial hypertension, transient cerebrovascular accident (including in the past).
The simultaneous use of Stopmigraine and drugs that contain ergotamine or its derivatives is prohibited. Stopmigren should not be used simultaneously with monoamine oxidase inhibitors and within fourteen days after their cancellation.
Stopmigraine is not used in patients under eighteen and over sixty-five years of age.
Application during pregnancy and lactation
During these periods, the anti-migraine drug Stopmigren is contraindicated.
Method of administration and dosage
Stopmigraine should not be used to prevent migraine attacks.
This pharmaceutical should be used as early as possible after the development of a migraine attack. Stopmigraine is usually received in fifty milligrams, in some cases – one hundred milligrams.
If the manifestations of migraine do not diminish, or do not disappear after receiving a dose of the drug, its repeated use is not recommended. But if, after the first dose received, the attack has ended or the symptoms have subsided, then with subsequent attacks that developed within the next twenty-four hours, it is allowed to reuse this drug, but not earlier than two hours after receiving the first dose.
The maximum dose of the pharmaceutical agent Stopmigren is three hundred milligrams / day.
In case of an overdose with Stopmigren, there is an increase in the side effects of this pharmaceutical.
In case of overdose, observation of the patient is required for at least ten hours; if necessary, symptomatic therapy is indicated. There is no specific antidote.
Side effects that may develop as a result of the use of the pharmaceutical drug Stopmigren may be as follows: arterial hypotension, nausea, tachycardia / bradycardia, transient hypertension, spasm of the coronary (cardiac) arteries, vomiting, palpitations, abdominal discomfort, weakness, dizziness, drowsiness, drowsiness (double vision), seizures (rare), nystagmus, decreased visual acuity, scotoma (loss of the area of vision), skin reactions (skin rash, itching, urticaria, erythema), sensations of heat and tingling, anaphylaxis (very rare), sensation severity, flushing, myalgia (muscle pain).
Storage conditions and periods
Store Stopmigren tablets in their original packaging at temperatures up to + 25 ° C.
It is necessary to protect this pharmaceutical product in places inaccessible to the child.
The shelf life is three years.